Small Molecules
10 April 2020
FirstWave Bio to Initiate Phase 2a/2b Study of FW-1022, a Proprietary Form of Niclosamide, to Treat COVID-1910 April 2020
BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-197 April 2020
Can-Fite Reports Positive Top Line Results from its Phase II NASH Study with Namodenoson7 April 2020
Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in CancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports